A critical look at the debate around contact precautions for MRSA carriers
This blog aims to provide a more nuanced analysis of the pro/con debate in the New England Journal of Medicine (NEJM) on whether to continue contact precautions for MRSA carriers.
Jan 256 min read
Beta-Lactam Treatment Options for Carbapenem-Resistant Organisms: A Practical Guide
Antimicrobial resistance poses a growing global threat to public health, directly causing an estimated 1.27 million deaths in 2019 alone (1). In clinical practice, this rise in resistance means clinicians will increasingly encounter infections where carbapenems - the once, reliable last-line agents - are ineffective. Since resistance mechanisms can often be determined before susceptibility results are available, this blog provides a schematic overview of beta-lactam treatment
Jan 73 min read
Is piperacillin-tazobactam still a valid option for treating infections by ESBL-producing bacteria?
1. What was the impact of the MERINO study on treatment approaches of ESBL-producing infections?
2. Why MERINO study’s intrinsic flaws may invalidate its conclusions?
3. How to deal with the results from the MERINO study?
Dec 18, 20257 min read
Influenza treatment - anything to add?
1. What is the role of corticosteroids in treating influenza?
2. Should antibiotics - particularly macrolides - be used for severe influenza infections?
3. What evidence exists for other therapies in influenza-related ARDS
Dec 4, 20256 min read